# Cells of Monocytic Origin as Surrogate Markers for Individual Drug Effects and Hepatotoxicity

> **NCT02353455** · — · UNKNOWN · sponsor: **Andreas Benesic, MD** · enrollment: 300 (estimated)

## Conditions studied

- Drug-induced Disorder of Liver
- Adverse Reaction to Drug

## Interventions

- **PROCEDURE:** Blood sampling

## Key facts

- **NCT ID:** NCT02353455
- **Lead sponsor:** Andreas Benesic, MD
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-03
- **Primary completion:** 2020-03
- **Final completion:** 2022-08
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2019-11-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02353455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02353455, "Cells of Monocytic Origin as Surrogate Markers for Individual Drug Effects and Hepatotoxicity". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02353455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*